Which of the following has the least 5 year survival rate following allogenic bone marrow transplantation?
**Core Concept**
Bone marrow transplantation, also known as hematopoietic stem cell transplantation, is a treatment for various blood-related disorders, including leukemia, lymphoma, and other hematological malignancies. The success of the transplant depends on several factors, including the type of disease, the age and overall health of the patient, and the compatibility of the donor.
**Why the Correct Answer is Right**
The least 5-year survival rate following allogenic bone marrow transplantation is observed in patients with acute leukemia, particularly acute myeloid leukemia (AML) with adverse cytogenetic features. This is because AML with adverse cytogenetics is more resistant to chemotherapy and has a higher risk of relapse after transplantation. Additionally, the presence of adverse cytogenetics in AML is associated with a poorer prognosis and lower overall survival rates.
**Why Each Wrong Option is Incorrect**
**Option A:** Aplastic anemia has a relatively good prognosis after bone marrow transplantation, with a 5-year survival rate of around 80-90%. This is because aplastic anemia is often treated with a matched sibling donor, which reduces the risk of graft-versus-host disease (GVHD) and other complications.
* **Option B:** Chronic lymphocytic leukemia (CLL) has a variable prognosis after bone marrow transplantation, but the 5-year survival rate is generally higher than that of acute leukemia. CLL patients who undergo transplantation often have a better prognosis than those with acute leukemia.
* **Option C:** Multiple myeloma has a relatively poor prognosis after bone marrow transplantation, but the 5-year survival rate is still higher than that of acute leukemia. The prognosis of multiple myeloma has improved in recent years with the use of newer treatments and transplantation.
**Clinical Pearl / High-Yield Fact**
When evaluating the prognosis of patients undergoing bone marrow transplantation, it is essential to consider the underlying disease, the age and overall health of the patient, and the compatibility of the donor. A thorough understanding of the disease-specific risks and benefits of transplantation is crucial for making informed decisions.
**Correct Answer:** D.